✦ LIBER ✦

Cost effectiveness of paliperidone palmitate versus risperidone long-acting injectable and olanzapine pamoate for the treatment of patients with schizophrenia in Sweden

✍ Scribed by Mehnert, Angelika; Nicholl, Deborah; Pudas, Hanna; Martin, Monique; McGuire, Alistair

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost Effectiveness of Paliperidone Palmi

✍ Casallas, C.; Ariza, J.G. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PMH23 A Cost-Effectiveness Analysis of t

✍ T.R. Einarson; H. Pudas; R. Zilbershtein; R. Jensen; A.T. Nielsen; C. Piwko; M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMH24 Cost of Long-Acting Risperidone In

✍ V. Omelyanovsky; M. Avxentyeva; O. Ivakhnenko; P. Khailov; F.M. Tsfasman; I. Kry 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH2 The COST-Effectiveness Of Paliperid

✍ Pudas, H.; Hemels, M.; Mehnert, A.; Druais, S.; Martin, M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PMH35 A Cost-Effectiveness Analysis of P

✍ T.R. Einarson; C. Vicente; R. Zilbershtein; C. Piwko 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PMH31 Cost-Effectiveness of Long-Acting

✍ T. Dilla; P. O'Donohoe; J. Möller; M. Álvarez; J. Sacristán; L. San; M. Happich; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB